PeerVoice Oncology & Haematology Audio

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

http://www.peervoice.com

Eine durchschnittliche Folge dieses Podcasts dauert 19m. Bisher sind 258 Folge(n) erschienen. Dieser Podcast erscheint wöchentlich.

Gesamtlänge aller Episoden: 4 days 10 hours 39 minutes

subscribe
share






The Role of Molecular Monitoring for CML: Getting the Expert’s Take


The Role of Molecular Monitoring for CML: Getting the Expert’s Take


share








 2015-07-24  10m
 
 

Individualizing Treatment Choices for Metastatic Melanoma: Which Therapy Is Best for Which Patient?


Go online to www.peervoice.com/h/pvr197 to view the entire programme with slides.


share








 2015-07-22  18m
 
 

Fine-Tuning Management of Advanced NSCLC: Clinical Implications of EGFR Mutations and Histology


Go online to www.peervoice.com/h/pve72 to view the entire programme with slides.


share








 2015-07-10  1h5m
 
 

The Evolving Treatment Landscape in Gastric Cancer: How Will Targeted Therapy Affect Clinical Practice?


Go online to www.peervoice.com/h/pve65 to view the entire programme with slides.


share








 2015-07-08  30m
 
 

Expert Perspectives: Treating by Mutation and Histology in Advanced NSCLC


Expert Perspectives: Treating by Mutation and Histology in Advanced NSCLC


share








 2015-07-06  20m
 
 

Expert Insights: A Practical Guide to ALK Testing in Advanced NSCLC


Expert Insights: A Practical Guide to ALK Testing in Advanced NSCLC


share








 2015-07-01  42m
 
 

Tailoring Treatment for Breakthrough Cancer Pain: Insights From a Multidisciplinary Perspective


Go online to www.peervoice.com/h/pve66 to view the entire programme with slides.


share








 2015-06-24  30m
 
 

Options to Reduce Risk of Febrile Neutropenia: How Do the Experts Decide?


Options to Reduce Risk of Febrile Neutropenia: How Do the Experts Decide?


share








 2015-06-23  32m
 
 
share








 2015-06-08  23m
 
 

Improving Outcomes in Acute Promyelocytic Leukaemia Through Early and Risk-Adapted Treatment


Go online to www.peervoice.com/h/pvr191 to view the entire programme with slides.


share








 2015-05-07  22m